Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00635609 · ClinicalTrials.gov registry record · Phase 4
Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate
A Phase 4 study, sponsored by Warner Chilcott.
- Completed
- Registry status
- Phase 4
- Development phase
- 93
- Enrollment target
NCT00635609 is a Phase 4 study that has completed, run by Warner Chilcott. The registered enrollment target is 93 participants.
The verdict
NCT00635609, a Phase 4 study, has completed, sponsored by Warner Chilcott.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 93 participants
- Enrollment target
Study Summary
Randomized, multi-center, open label, active-comparator study to compare the efficacy and tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with moderate to severe acne vulgaris.
Interventions
- DRUG Doxycycline hyclate
- DRUG Doxycycline hyclate (Doryx)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 93 participants |
| Start Date | 2008-03 |
| Est. Completion | 2008-09 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00635609
The ClinicalTrials.gov registry entry for NCT00635609 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 93 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Warner Chilcott, which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Doxycycline hyclate is the first listed.
NCT00635609 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00635609 about?
NCT00635609 is a clinical study titled "Treatment of Acne Vulgaris With Doryx Tablets Compared to Doxycyline Hyclate". Randomized, multi-center, open label, active-comparator study to compare the efficacy and tolerability of Doryx Delayed Release Tablets to doxycycline hyclate in patients with moderate to severe acne vulgaris.
What is the current status of trial NCT00635609?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 93 participants. The study started on 2008-03. Estimated completion is 2008-09.
What interventions are being tested in trial NCT00635609?
The interventions under investigation include: Doxycycline hyclate (DRUG), Doxycycline hyclate (Doryx) (DRUG).
Who is sponsoring clinical trial NCT00635609?
This trial is sponsored by Warner Chilcott, which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.